期刊文献+

类固醇生成因子1及细胞角蛋白8在垂体腺瘤中的表达及意义

The expression and role of steroidogenic factor-1 and CK8 in pituitary adenoma
下载PDF
导出
摘要 目的探讨类固醇生长因子1(SF1)和细胞角蛋白8(CK8)在垂体腺瘤分类中的指导作用。方法收集垂体腺瘤49例,检测SF1和CK8在垂体腺瘤中的表达,分析二者在不同类型垂体腺瘤中的表达特点。结果 SF1在促性腺激素细胞腺瘤中的阳性表达率(90%,18/20)明显高于其他类型垂体腺瘤(0);CK8在SF1阳性的垂体腺瘤中的高表达率(21%,5/24)明显低于SF1阴性的垂体腺瘤(92%,23/25)。结论 SF1对促性腺激素细胞腺瘤有极高的诊断价值;CK8阴性或低表达是促性激素细胞腺瘤的分子特征之一,可以辅助用于垂体腺瘤的分类。 Objective To investigate the role of SF1 and CK8 in the classification of pituitary adenomas. Methods The ex- pressions of SF1 and CK8 in 49 pituitary adenomas were detected by immunohistochemistry. The difference of the expression (SF1 and CK8) in multiple pituitary adenoma were analyzed. Results The rate of SF1 positive staining in gonadotroph adenoma (90%, 18/20) was significantly higher than that in other pituitary adenoma types (0% ,0/11) (P〈0. 01) ;the rate of CK8 high expres- sion in SF1 immunopositive pituitary adenoma (5/24,21 %) was significantly lower than that in SF1 immunonegative pituitary ad- enoma (23/25,920/00). Conclusion SF-1 is a key molecular event and play a important role in the diagonosis of gonadotroph adeno- ma. CK8 immunonegative or low expression is one of the molecular characteristics of the gonadotroph adenoma, and it can be used for the classification of pituitary adenoma.
作者 吴会芳 王俊宽 常佳 顾斌 冯怡锟 杨婉菁 张岩 胡桂明 陈琛 任景丽 WU Huifang1) ,WANG Junkuan2) , CHANG J ia1) , GU Bin1) , FENG Yikun1) , YANG Wanjing1) , ZHANG Yan1), HU Guim- ing1) ,CHEN Chen1) ,REN Jingli1)*(1 )Department of Pathology, the Second Affiliated Hospital of Zhengzhou University ,Zhengzhou 450014 ,China;2)Department of Neurosurgery , the First Affiliated Hospital of Zhengzhou University ,Zhenzhou 450052, China)
出处 《中国实用神经疾病杂志》 2018年第4期353-356,共4页 Chinese Journal of Practical Nervous Diseases
基金 河南省自然科学基金(162300410307)
关键词 垂体腺瘤 类固醇生长因子1 细胞角蛋白8 促性腺激素细胞腺瘤 免疫组织化学 Pituitary adenoma Steroidogenic factor-1 Cytokeratin 8 Gonadotroph adenoma Immunohistochemistry
  • 相关文献

参考文献5

二级参考文献39

  • 1Yasargil MG. Microneurosurgery[M]. New York: Georg Thi- eme Verlag, 1984 : 213-251.
  • 2Marucci G, Faustini-Fustini M, Righi A, et al. Thyrotropin-se- creting pituitary tumours: significance of "atypical adenomas" in a series of 10 patients and association with Hashimoto thy- roiditis as a cause of delay in diagnosis[J]. J Clin Pathol, 2009, 62(5) :455-459.
  • 3Knosp E, Steiner E, Kitz K, et al. Pituitary adenomas with inva- sion of the cavernous sinus space:a magnetic resonance imaging classification compared with surgical findings [J]. Neurosurger- y,1993,33(4) :610-618.
  • 4Salehi F, Agur A, Scheithauer BW, et al. Ki-67 in pituitary neo- plasms: a review-part I [J]. Neurosurgery, 2009,65 (3) : 429-437.
  • 5Scheithauer BW, Gaffey TA, Lloyd RV, et al: Pathohiology of pituitary adenomas and carcinomas[J]. Neurosurgery, 2006,59 (2) :341-353.
  • 6Golden SH, Robinson KA, Saldanha I, et al. Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review[J]. J Clin Endocrinol Metab, 2009,94(6):1853-1878.
  • 7Fassnacht M, Terzolo M, Allolio B, et al. Combination chemotherapy in advanced adrenocortical carcinoma[J]. N Engl J Med, 2012,366(23):2189-2197.
  • 8Fassnacht M, Libé R, Kroiss M, et al. Adrenocortical carcinoma: a clinician′s update[J]. Nat Rev Endocrinol, 2011,7(6):323-335.
  • 9Papotti M, Libè R, Duregon E, et al. The Weiss score and beyond-histopathology for adrenocortical carcinoma[J]. Horm Cancer, 2011,2(6):333-340.
  • 10Soon PS, McDonald KL, Robinson BG, et al. Molecular markers and the pathogenesis of adrenocortical cancer[J]. Oncologist, 2008,13(5):548-561.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部